Imported from EML workbook.
Formulations: - Oral > Liquid: 100 mg per 5 mL powder for oral liquid Oral > Solid: 200 mg (as trihydrate); 400 mg (as trihydrate) Indications: - Infectious gastroenteritis or colitis without specification of infectious agent - Gonococcal infection Source: EML workbook import
Formulations: - Parenteral > General injections > unspecified: 250 mg in vial (as pentahydrate) powder for injection; 1 g in vial (as pentahydrate) powder for injection Indications: - Endophthalmitis - Pseudomonas aeruginosa resistant to other antibiotic Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 250 mg in vial (as sodium salt) powder for injection; 750 mg in vial (as sodium salt) powder for injection; 1.5 g in vial (as sodium salt) powder for injection Indications: - Other specified prophylactic measures Source: EML workbook import
Formulations: - Oral > Liquid: 125 mg per 5 mL powder for oral liquid; 250 mg per 5 mL powder for oral liquid Parenteral > General injections > unspecified: 500 mg in vial powder for injection Oral > Solid > dosage form: 500 mg; 250 mg Oral > Solid > dosage form: 500 mg Indications: - Bacterial pneumonia (Community-acquired pneumonia - severe) - Acute pharyngitis - Helicobacter pylori associated gastric ulcer Alternatives: - cefotaxime - ceftriaxone - amoxicillin + clavulanic acid Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 2 g (as sodium salt) + 250 mg (as sodium salt) powder for injection; 4 g (as sodium salt) + 500 mg (as sodium salt) powder for injection Indications: - Neutropenia (high-risk) - Other specified pneumonia (Hospital-acquired pneumonia) - Peritonitis (severe) - Peritoneal abscess (severe) - Necrotising fasciitis Alternatives: - clindamycin Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 250 mg in vial (as hydrochloride) powder for injection Oral > Solid > capsule: 125 mg (as hydrochloride); 250 mg (as hydrochloride) Parenteral > General injections > IV: 250 mg in vial (as hydrochloride) powder for injection; 500 mg in vial (as hydrochloride) powder for injection; 1 g in vial (as hydrochloride) powder for injection Parenteral > Locoregional injections > Intravitreal: 250 mg in vial (as hydrochloride) powder for injection; 500 mg in vial (as hydrochloride) powder for injection; 1 g in vial (as hydrochloride) powder for injection Indications: - Intestinal infections due to Clostridioides difficile Source: EML workbook import
Formulations: - Oral > Liquid: 200 mg per 5 mL (anhydrous) powder for oral liquid Oral > Solid > dosage form: 250 mg (anhydrous); 500 mg (anhydrous) Indications: - Trachoma - Cholera - Cholera [children] - Paratyphoid fever - Chlamydia trachomatis - Typhoid fever - Yaws - Gonococcal infection - Infectious gastroenteritis or colitis without specification of infectious agent Alternatives: - ceftriaxone - cefixime Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 500 mg in vial powder for injection (as lactobionate) Oral > Liquid: 125 mg per 5 mL (as stearate or ethylsuccinate) Oral > Solid: 250 mg (as stearate or ethylsuccinate) Indications: - Acute pharyngitis Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 2 mg per mL (as hyclate) Oral > Liquid: 250 mg per 5 mL (anhydrous) Oral > Solid: 250 mg (as hydrochloride) Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride); 100 mg (as hydrochloride) Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride) Indications: - Acute pyelonephritis (mild to moderate) - Infectious gastroenteritis or colitis without specification of infectious agent - Paratyphoid fever - Typhoid fever - Neutropenia (low-risk) - Inflammatory and other diseases of prostate (mild to moderate) - Cholera - Cholera [children] - Peritonitis (mild-moderate) - Peritoneal abscess (mild-moderate) - Bacterial infection of unspecified site Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 250 mg (as monohydrate) + 250 mg (as sodium salt) powder for injection; 500 mg (as monohydrate) + 500 mg (as sodium salt) powder for injection Indications: - Peritonitis (severe) - Peritoneal abscess (severe) - Neutropenia (high-risk) Source: EML workbook import
Ready to amplify your rewards? Drop your email and we'll be in touch soon.
